How gut bacteria relate to blood cancer and HLH
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at the bacteria in your body (your microbiome) and how they might be connected to blood cancers and a rare condition called HLH. By joining, you help researchers learn more about these diseases, which may lead to better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older.
- You have a blood cancer or have been diagnosed with HLH by a doctor.
- You don't have HIV, hepatitis B, hepatitis C, or an active infection like COVID-19.
- You are willing to provide a sample for the study (such as blood or stool).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks for a DNA marker in people with HLH caused by lymphoma. It may help doctors better confirm the cause of HLH and guide treatment decisions.
This study collects samples and health information from people with certain blood cancers to learn more about the disease and find markers that may help guide future treatments. You will not receive a treatment from this study, but you may help advance research.
This study looks at how the bacteria in your gut change during cancer treatment (and during some blood stem cell transplants). It may help researchers understand why some people respond differently and guide better future treatment.
This study is for people with hemophagocytic lymphohistiocytosis (HLH), a condition where the immune system becomes overactive. Researchers want to collect medical data and blood samples to better understand HLH and find better ways to diagnose and treat it.
This study collects human samples (like blood or other specimens) to learn more about hairy cell leukemia and other leukemias. It also helps researchers develop new lab-made immune-based medicines for cancer treatment.
This study looks at certain markers on your blood cancer cells to understand them better. By joining, you help doctors learn more about your disease, which may guide future care.
Hear when a new Haemophagocytic Lymphohistiocytosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.